Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis

Journal of Internal Medicine

Volumn 240, Issue 6, 1996, Pages 373-380

  Wållberg Jonsson, Solveig ^a,c   Dahlén, Gösta ^a   Johnson, Owe ^a   Olivecrona, Gunilla ^b   Rantapää Dahlqvist, Solbritt ^a  

^a University Hospital   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Inflammation; LDL receptr related protein; Lipid load; Lipoprotein lipase mass; Rheumatoid arthritis

Indexed keywords

CYTOKINE; HEPARIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIPID BLOOD LEVEL; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

EID: 0030458807     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.53873000.x     Document Type: Article

References (37)

1. Isomäki HA, Mutru O, Koota K. Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 1975; 4: 205-8.
2. Allebeck P, Ahlbom A, Alander E. Increased mortality among patients with rheumatoid arthritis, but where RA does not appear on the death certificate. Scand J Rheumatol 1981; 10: 301-6.
3. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to a simple questionnaire and joint count measures. Ann Intern Med 1994; 120: 26-34.
4. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
5. Mutru O. Laakso M, Isomäki H, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 1989; 76: 71-7.
6. Myllykangas-Luosujärvi R. Aho K. Kautiainen H, Isomäki H. Cardiovascular mortality in females with rheumatoid arthritis. J Rheumatol 1995; 22: 1065-7.
7. Prior P, Symmons DPM, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheum 1984; 23 92-9.
8. Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982; 11: 81-6.
9. Monson RR, Hall AP. Mortality among arthritics. J Cron Dis 1976; 29: 459-67.
10. Karten I. Arteritis, myocardial infarction and rheumatoid arthritis. JAMA 1969; 210: 1717-20.
11. Lazarevic MB, Vitic J, Mladenovic V, Myones BL, Skosey JL, Swedler WI. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum 1992; 22: 172-80.
12. Rössner S. Loøfmark C. Dyslipoproteinemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis 1977; 28: 41-52.
13. Svenson KLG, Lithell H, Hällgren R, Selinus I, Vessby B. Altered serum lipoproteins and enhanced lipoprotein elimination in patients with rheumatoid arthritis and other chronic inflammatory arthritides. Arch Intern Med 1987; 147: 1912-6.
14. Rantapää-Dahlqvist S, Wållberg-Jonsson S. Dahlén G. Lipoprotein (a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991; 50: 366-8.
15. Patsch JR, Miesenböck G, Hopferweiser T, Mühlberger V, Knapp E, Dunn JK et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Artherioscler Thromb 1992; 12: 1336-45.
16. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989; 320: 1060-8.
17. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Pror Natl Acad Sci USA, 1991; 88: 8342-6.
18. 2macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and β-migrating very low density lipoprotein associated with the lipase. J Biol Chem 1993; 268: 15048-55.
19. Eisenberg S, Sehayek E, Olivecrona T. Vlodavsky I. Lipoprotein lipase binding of lipoproteins to heparin sulfate on cell surfaces and extracellular matrix. J Clin Invest 1992; 90: 2013-21.
20. Santamarina-Fojo S, Dugi K. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr Opin Lipidol 1994; 5: 117-25.
21. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 1995; 6: 291-305.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum 1988; 31: 315-24.
23. Karpe F, Bard J-M, Steiner G, Carlson LA, Fruchart J-C, Hamsten A. HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. Arterioscler Thromb 1993; 13: 11-22.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
25. Bengtsson-Olivecrona G, Olivecrona T. Lipoprotein analysis. A practical approach. In: Converse C, Skinner ER, eds. Assay of Lipoprotein Lipase and Hepatic Lipase. Oxford: IRL Press, 1992; 169-85.
26. Karpe F, Olivecrona T, Waldius G, Hamsten A. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res 1992; 33: 975-84.
27. Vilella E, Joven J, Fernándes M, Vilaró S, Brunzell JD, Olivecrona T et al. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Res 1993; 34: 1555-64.
28. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 1995; 15: 1086-93.
29. 2macroglobulin receptor/low density lipoprotein receptor related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 1994; 93: 2014-21.
30. Nykjaer A, Nielsen M, Lookene A. Meyer N. Roigaard H. Etzerodt M et al. A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor related protein and inhibits lipase mediated uptake of lipoprotein in cells. J Biol Chem 1994; 269: 31747-55.
31. Krapp A, Zhang H, Ginzinger D, Liu M-S, Lindberg A, Olivecrona G et al. Structural features in lipoprotein lipase necessary for the mediation of Iipoprotein uptake into cells. J Lipid Res 1995; 36: 2362-73.
32. Ylä-Heretula S, Lipton BA, Rosenfeld ME, Goldberg IJ, Steinberg D, Witztum JL. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 10143-7.
33. Ehnholm C, Aho K, Huttunen JK, Kostiainenen E, Mattila K, Pikkarainen J et al. Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases. Arteriosclerosis 1982; 2: 68-73.
34. Beutler BA, Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 1985; 135: 3969-71.
35. Semb H, Peterson J, Tavernier J, Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 1987; 262: 8390-4.
36. 2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of the lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341-7.
37. Weintraub MS. Eisenberg S, Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal, type Ua. type III. and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest 1987; 79: 1110-9.